Both hypothyroidism and hyperthyroidism during pregnancy are associated with a higher risk of excessive bleeding, according to new research published in Thyroid Research. The findings highlight an often-overlooked connection between thyroid hormone imbalances and pregnancy complications, suggesting that thyroid management may be more critical for pregnant women than previously understood.

What Does the Research Show About Thyroid Disease and Pregnancy Bleeding?

Researchers in Denmark analyzed data from over 1.1 million pregnancies between 1999 and 2015 to examine the link between abnormal thyroid hormone levels and bleeding risk. The study included 27,674 pregnancies affected by maternal hypothyroidism (an underactive thyroid) and 17,702 pregnancies affected by maternal hyperthyroidism (an overactive thyroid).

The results revealed that both conditions carried measurable risks. Women with hyperthyroidism diagnosed before or during pregnancy were 11% more likely to experience early pregnancy bleeding compared to women with normal thyroid function. Similarly, women with hypothyroidism diagnosed before or during pregnancy faced an 11% increased risk of early bleeding.

For late-pregnancy bleeding, the pattern differed slightly. Only hypothyroidism diagnosed after pregnancy showed a significant association, with a 22% increased risk of late bleeding complications. The researchers emphasized that these findings warrant further investigation into how thyroid hormones influence the body's bleeding and clotting mechanisms.

Why Does Thyroid Disease Affect Bleeding During Pregnancy?

Thyroid hormones play a crucial role in hemostasis, the body's ability to control bleeding and form blood clots. These hormones also regulate tissue repair and many other organ system processes. When thyroid hormone levels are abnormal, they can disrupt these delicate mechanisms, potentially increasing the risk of excessive bleeding during pregnancy.

The study examined whether specific thyroid hormone measurements, such as TSH (thyroid-stimulating hormone) and free T4 (thyroxine), directly predicted postpartum hemorrhage risk. Interestingly, when researchers analyzed these hormone levels as continuous variables, they found no significant association with postpartum bleeding volume, suggesting that the relationship between thyroid disease and bleeding may be more complex than simple hormone level thresholds.

How Should Pregnant Women Manage Thyroid Conditions?

• Early Screening: Women planning pregnancy or already pregnant should discuss thyroid screening with their healthcare provider, especially if they have a family history of thyroid disease or autoimmune conditions like Hashimoto's or Graves disease.
• Regular Monitoring: If thyroid disease is diagnosed before or during pregnancy, consistent monitoring of thyroid hormone levels and medication adjustments may help reduce bleeding complications and support healthy pregnancy outcomes.
• Multidisciplinary Care: Pregnant women with thyroid disorders should work closely with both their obstetrician and endocrinologist to ensure coordinated care and appropriate treatment throughout pregnancy and the postpartum period.

The study authors noted that their findings provide important clues about the connection between maternal thyroid disease and bleeding outcomes. "This result provides clues on an association between maternal thyroid disease in pregnancy and bleeding outcomes and support further investigations on the hypothesis that specifically hypothyroidism associates with an increased risk of bleeding," the researchers stated.

What Are the Study's Limitations?

While the research involved a large population and used reliable national health registers, the study had some constraints. Researchers relied on routinely collected medical records with limited variables, and they were unable to assess changes in maternal thyroid function throughout pregnancy. Additionally, some thyroid disease diagnoses were made after pregnancy, which may not fully capture the timing of thyroid dysfunction during the pregnancy itself.

Despite these limitations, the study provides valuable evidence that thyroid disease should be considered a potential risk factor for pregnancy bleeding complications. Healthcare providers may use these findings to inform more comprehensive screening and management protocols for pregnant women with thyroid disorders, potentially reducing adverse outcomes and improving maternal health during this critical period.